Ramon Mohanlal
Director/Board Member chez Seed Therapeutics, Inc.
Profil
Ramon W.
Mohanlal is currently a Director at Seed Therapeutics, Inc. Prior to his current position, he served as Director, Chief Medical Officer, and Executive VP-R&D at BeyondSpring, Inc. from 2015 to 2023.
Ramon also held positions as Chief Medical Officer at Vertex Pharmaceuticals, Inc., Clinical Head-Established Oncology Products at Novartis AG, and Chief Executive & Medical Officer at BioPremiere, Inc. He was also a Principal at Glaxo Wellcome Plc and Pharmacia Corp.
Ramon holds a doctorate from the University of Leiden and an MBA from American InterContinental University System, Inc.
Postes actifs de Ramon Mohanlal
| Sociétés | Poste | Début |
|---|---|---|
| Seed Therapeutics, Inc. | Director/Board Member | 01/08/2020 |
Anciens postes connus de Ramon Mohanlal
| Sociétés | Poste | Fin |
|---|---|---|
| BEYONDSPRING INC. | Chief Tech/Sci/R&D Officer | 16/02/2023 |
| NOVARTIS AG | Corporate Officer/Principal | 01/07/2015 |
BioPremiere, Inc.
 BioPremiere, Inc. Pharmaceuticals: MajorHealth Technology BioPremiere Inc. operates as a biopharmaceutical company. The company is headquartered in Boston, MA. | Chief Executive Officer | 01/01/2009 |
| INTERLEUKIN GENETICS, INC | Chief Tech/Sci/R&D Officer | 17/08/2007 |
| Glaxo Wellcome Plc | Corporate Officer/Principal | - |
Formation de Ramon Mohanlal
| American InterContinental University System, Inc. | Masters Business Admin |
| University of Leiden | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| NOVARTIS AG | Health Technology |
| BEYONDSPRING INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
| Glaxo Wellcome Plc | Health Technology |
Interleukin Genetics, Inc.
 Interleukin Genetics, Inc. Pharmaceuticals: MajorHealth Technology Interleukin Genetics, Inc. engages in the marketing and development of proprietary genetic tests for chronic inflammatory diseases and health-related conditions focuses on metabolism and inflammation. The company was founded in 1986 and is headquartered in Waltham, MA. | Health Technology |
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Health Technology |
BioPremiere, Inc.
BioPremiere, Inc. Pharmaceuticals: MajorHealth Technology BioPremiere Inc. operates as a biopharmaceutical company. The company is headquartered in Boston, MA. | Health Technology |
| Seed Therapeutics, Inc. |
